These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8147565

  • 1. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias.
    Mark MH, Sage JI.
    Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565
    [Abstract] [Full Text] [Related]

  • 2. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [Abstract] [Full Text] [Related]

  • 3. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR, Sage JI, Lang AE, Mark MH.
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [Abstract] [Full Text] [Related]

  • 4. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 5. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Parkinson's disease.
    Eadie MJ.
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
    Pezzoli G, Martignoni E, Pacchetti C, Angeleri VA, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E.
    Mov Disord; 1994 Jul; 9(4):431-6. PubMed ID: 7969210
    [Abstract] [Full Text] [Related]

  • 13. Bromocriptine in Parkinson disease.
    Lieberman AN, Goldstein M.
    Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
    [Abstract] [Full Text] [Related]

  • 14. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
    de Yébenes JG, García-Ruiz PJ, Sánchez-Pernaute R.
    Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
    Savery F.
    Dis Nerv Syst; 1977 Aug; 38(8):605-8. PubMed ID: 328244
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL, Rascol O, Rascol A.
    Rev Neurol (Paris); 1990 Aug; 146(2):144-7. PubMed ID: 2181588
    [Abstract] [Full Text] [Related]

  • 18. A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
    Bonnet AM, Serre I, Marconi R, Agid Y, Dubois B.
    Mov Disord; 1995 Sep; 10(5):668-71. PubMed ID: 8552122
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Parkinson's disease. From theory to practice.
    Ahlskog JE.
    Postgrad Med; 1994 Apr; 95(5):52-4, 57-8, 61-4 passim. PubMed ID: 8153048
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.